Enzyme immunoassay for measurement of murine plasminogen activator inhibitor-1, employing a specific antibody produced by the DNA vaccine method

Thrombosis Research

Volumn 111, Issue 4-5, 2003, Pages 285-291

  Yamada, Takayuki ^a,b   Takagi, Akira ^a   Takeshita, Kyosuke ^c   Yamamoto, Koji ^b   Ito, Masafumi ^b   Matsushita, Tadashi ^c   Murate, Takashi ^a   Saito, Hidehiko ^d,e   Kojima, Tetsuhito ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^e Aichi Blood Disease Research Foundation   (Japan)

Author keywords

DNA vaccine; Enzyme linked immunosorbent assay (ELISA); Lipopolysaccharide (LPS); Mouse; Plasminogen activator inhibitor 1 (PAI 1); Polyclonal antibody

Indexed keywords

DNA ANTIBODY; DNA VACCINE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; PLASMA PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; BIOACCUMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MOUSE; EXPRESSION VECTOR; IMMUNIZATION; IMMUNOPATHOLOGY; INTRASPECIFIC VARIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RABBIT; RELIABILITY; REPRODUCIBILITY;

EID: 0347063980     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.09.007     Document Type: Article

References (37)

1. Loskutoff D.J., Sawdey M., Mimuro J. Type 1 plasminogen activator inhibitor. Prog. Hemostasis Thromb. 9:1989;87-115.
2. Huber K. Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease. J. Thromb. Thrombolysis. 11:2001;183-193.
3. Potempa J., Korzus E., Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 269:1994;15957-15960.
4. Binder B.R., Christ G., Gruber F., Grubic N., Hufnagl P., Krebs M.et al. Plasminogen activator inhibitor 1: physiological and pathophysiological roles. News Physiol. Sci. 17:2002;56-61.
5. Kruithof E.K., Nicolosa G., Bachmann F. Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation. Blood. 70:1987;1645-1653.
6. Booth N.A., Simpson A.J., Croll A., Bennett B., MacGregor I.R. Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br. J. Haematol. 70:1988;327-333.
7. Schleef R.R., Loskutoff D.J. Fibrinolytic system of vascular endothelial cells. Role of plasminogen activator inhibitors. Haemostasis. 18:1988;328-341.
8. MacGregor I.R., Booth N.A. An enzyme-linked immunosorbent assay (ELISA) used to study the cellular secretion of endothelial plasminogen activator inhibitor (PAI-1). Thromb. Haemost. 59:1988;68-72.
9. Reilly C.F., McFall R.C. Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells. J. Biol. Chem. 266:1991;9419-9427.
10. Pinsky D.J., Liao H., Lawson C.A., Yan S.F., Chen J., Carmeliet P.et al. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J. Clin. Invest. 102:1998;919-928.
11. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:1998;3091-3100.
12. Fink T., Kazlauskas A., Poellinger L., Ebbesen P., Zachar V. Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1. Blood. 99:2002;2077-2083.
13. Reilly C.F., Fujita T., Mayer E.J., Siegfried M.E. Both circulating and clot-bound plasminogen activator inhibitor-1 inhibit endogenous fibrinolysis in the rat. Arterioscler. Thromb. 11:1991;1276-1286.
14. Kawasaki T., Dewerchin M., Lijnen H.R., Vermylen J., Hoylaerts M.F. Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice. Blood. 96:2000;153-160.
15. Yamamoto K., Saito H. A pathological role of increased expression of plasminogen activator inhibitor-1 in human or animal disorders. Int. J. Hematol. 68:1998;371-385.
16. Hamsten A., de Faire U., Walldius G., Dahlen G., Szamosi A., Landou C.et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 2:1987;3-9.
17. Huber K., Christ G., Wojta J., Gulba D. Plasminogen activator inhibitor type-1 in cardiovascular disease status report 2001. Thromb. Res. 103:2001;S7-S19.
18. Wiman B., Hamsten A. The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease. Semin. Thromb. Hemost. 16:1990;207-216.
19. Pralong G., Calandra T., Glauser M.P., Schellekens J., Verhoef J., Bachmann F.et al. Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb. Haemost. 61:1989;459-464.
20. Olman M.A., Mackman N., Gladson C.L., Moser K.M., Loskutoff D.J. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J. Clin. Invest. 96:1995;1621-1630.
21. Keeton M., Ahn C., Eguchi Y., Burlingame R., Loskutoff D.J. Expression of type 1 plasminogen activator inhibitor in renal tissue in murine lupus nephritis. Kidney Int. 47:1995;148-157.
22. Yamamoto K., Loskutoff D.J., Saito H. Renal expression of fibrinolytic genes and tissue factor in a murine model of renal disease as a function of age. Semin. Thromb. Hemost. 24:1998;261-268.
23. Schneiderman J., Sawdey M.S., Keeton M.R., Bordin G.M., Bernstein E.F., Dilley R.B.et al. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. U. S. A. 89:1992;6998-7002.
24. Chomiki N., Henry M., Alessi M.C., Anfosso F., Juhan-Vague I. Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls. Thromb. Haemost. 72:1994;44-53.
25. Hashimoto Y., Kobayashi A., Yamazaki N., Sugawara Y., Takada Y., Takada A. Relationship between age and plasma t-PA, PA-inhibitor, and PA activity. Thromb. Res. 46:1987;625-633.
26. Yamamoto K., Shimokawa T., Yi H., Isobe K., Kojima T., Loskutoff D.J.et al. Aging accelerates endotoxin-induced thrombosis: increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging. Am. J. Pathol. 161:2002;1805-1814.
27. Yamamoto K., Takeshita K., Shimokawa T., Yi H., Isobe K., Loskutoff D.J.et al. Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals. Proc. Natl. Acad. Sci. U. S. A. 99:2002;890-895.
28. Declerck P.J., Verstreken M., Collen D. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Thromb. Haemost. 74:1995;1305-1309.
29. Ishiguro K., Kojima T., Kadomatsu K., Nakayama Y., Takagi A., Suzuki M. et al. Complete antithrombin deficiency in mice results in embryonic lethality. J. Clin. Invest. 106:2000;873-878.
30. Springer T.A. Purification of proteins by precipitation. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. Current protocols in molecular biology. 1987;10.16.1-10.16.11 Wiley, New York.
31. Kunishima S., Hayashi K., Kobayashi S., Naoe T., Ohno R. New enzyme-linked immunosorbent assay for glycocalicin in plasma. Clin. Chem. 37(2):1991;169-172.
32. Liu M.A. Overview of DNA vaccines. Ann. N.Y. Acad. Sci. 772:1995;15-20.
33. Liu M.A. DNA vaccines: a review. J. Intern. Med. 253(4):2003;402-410.
34. Wolff J., Malone R., Williams P., Chong W., Acsadi G., Jani A.et al. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
35. Katsumi A., Emi N., Abe A., Hasegawa Y., Ito M., Saito H. Humoral and cellular immunity to an encoded protein induced by direct DNA injection. Hum. Gene Ther. 5:1994;1335-1339.
36. Declerck P.J., Collen D. Measurement of plasminogen activator inhibitor 1 (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assays. Thromb. Res., Suppl. 10:1990;3-9.
37. Declerck P.J., Moreau H., Jespersen J., Gram J., Kluft C. Multicenter evaluation of commercially available methods for the immunological determination of plasminogen activator inhibitor-1 (PAI-1). Thromb. Haemost. 70(5):1993;858-863.